查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2111442

2026年全球植入式神經調控與脊髓刺激設備市場報告

Implantable Neuromodulation And Spinal Cord Stimulation Devices Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，植入式神經調控和脊髓刺激設備的市場規模迅速擴張。預計該市場規模將從2025年的93.1億美元成長到2026年的105.3億美元，複合年成長率（CAGR）為13.1%。這一成長主要歸因於慢性疼痛在全球範圍內日益普遍、脊髓刺激療法在疼痛管理中的應用不斷擴大、神經系統治療基礎設施的完善、植入式醫療設備的接受度不斷提高以及植入式脈衝發生器技術的快速發展。

預計未來幾年，植入式神經調控和脊髓刺激設備的市場規模將快速成長。預計到2030年，該市場將以12.6%的複合年成長率成長，達到169.6億美元。預測期內的成長預計將受到以下因素的驅動：人工智慧驅動的自適應神經調控系統的整合、對微創神經療法的需求不斷成長、個人化和精準神經療法的推廣、無線植入式醫療設備的日益普及以及封閉回路型神經刺激技術的進步。預測期內的關鍵趨勢包括：封閉回路型自適應神經調控系統在最佳化即時疼痛管理方面的應用日益廣泛；對可充電植入式脈衝發生器的需求不斷成長，以減少手術更換次數；脊髓刺激設備在慢性疼痛和神經病變疾病治療中的應用日益增多；無線和遠程可程式設計薦骨神經調控設備在提供個性化治療方面的廣泛性治療以及應用神經性治療方面的廣泛性；

神經系統疾病盛行率的不斷上升預計將推動植入式神經調控和脊髓刺激設備市場的成長。神經系統疾病是指損害大腦、脊髓或周圍神經功能的神經系統疾病，會導致身體、認知或行為異常。隨著糖尿病盛行率的上升，神經系統疾病的發生率也增加。這是因為長期高血糖會損害神經和血管，增加神經病變、中風和認知障礙等神經系統疾病的風險。植入式神經調控和脊髓刺激器透過向脊髓和大腦的特定神經或區域傳遞可控的電脈衝來幫助控制神經系統疾病，有助於減輕慢性疼痛、恢復神經訊號並改善帕金森氏症、癲癇和脊髓損傷等疾病的相關症狀。例如，根據澳洲政府機構澳洲健康與福利研究所（AIHW）的數據，截至2025年12月，約有42.5萬澳洲人患有失智症（一種神經系統疾病），預計到2065年，這一數字將增加2.5倍，超過110萬。其中，預計約有66.2萬為女性，39萬為男性。因此，神經系統疾病發生率的上升正在推動植入式神經調節器和脊髓刺激設備市場的成長。

醫療保健支出不斷成長預計將推動植入式神經調節器和脊髓刺激設備市場的發展。醫療保健支出是指政府、組織和個人在醫療服務、醫療產品以及旨在維持或改善健康的活動上的總支出。醫療技術的進步是醫療保健支出不斷成長的主要原因。創新診斷工具、機器人手術和先進療法的引入雖然改善了患者照護，但也增加了醫療保健服務的整體成本。醫療保健支出的成長透過以下方式促進了植入式神經調節器和脊髓刺激器市場的發展：增加對先進疼痛管理技術的投資，改善患者獲得植入式治療的機會，以及擴大用於治療特定神經系統疾病的醫療基礎設施。例如，根據英國國家統計局（總部位於英國的獨立公共統計機構）的數據，截至2025年4月，預計英國2024年的醫療保健支出將達到約3707.1億美元（3170億英鎊），與2023年相比名義增加6.5%。因此，不斷上漲的醫療保健成本正在推動植入式神經調節器和脊髓刺激設備市場的成長。

目錄

第1章：執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球植入式神經調控與脊髓刺激設備市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略適宜性評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 清單：主要原料、資源和供應商
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章：全球市場趨勢與策略

  • 關鍵科技與未來趨勢
    • 生物技術、基因組學和精準醫療
    • 數位化、雲端運算、巨量資料、網路安全
    • 人工智慧和自主智慧
    • 物聯網、智慧基礎設施、互聯生態系統
    • 身臨其境型技術（AR/VR/XR）與數位體驗
  • 主要趨勢
    • 擴大封閉回路型自適應神經調節系統的應用，以最佳化即時疼痛管理。
    • 為了減少手術更換的需要，人們對可充電植入式脈衝產生器的需求日益成長。
    • 擴大脊髓刺激設備在慢性疼痛和神經病變疾病的應用
    • 拓展無線和遠端可程式設計神經調節設備，以提供個人化治療。
    • 薦骨神經調節裝置在膀胱和腸道功能障礙治療的應用正在不斷推進。

第5章 終端用戶產業市場分析

  • 醫院及綜合醫療中心
  • 門診手術中心
  • 疼痛專科診所
  • 神經內科和神經外科診所
  • 其他

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及 COVID-19 疫情對市場的影響。

第7章：全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球植入式神經調控與脊髓刺激設備市場：PESTEL 分析
  • 全球植入式神經調節與脊髓刺激設備市場：規模、對比和成長率分析
  • 全球植入式神經調控與脊髓刺激設備市場表現：規模與成長，2020-2025年
  • 全球植入式神經調控與脊髓刺激設備市場預測：規模與成長，2025-2030年，2035年

第8章：全球市場總規模（TAM）

第9章 市場細分

  • 依設備類型
  • 脊髓刺激設備、深部腦部刺激器、薦骨神經調節器、周邊神經刺激設備、迷走神經刺激設備
  • 透過技術
  • 封閉回路型自適應系統、可充電植入式脈衝產生器、不可充電植入式脈衝產生器、無線和遠端可程式系統
  • 透過使用
  • 慢性疼痛、帕金森氏症和運動障礙的治療，脊髓損傷和癱瘓的康復，膀胱和腸道功能障礙，癲癇和神經系統疾病的治療。
  • 最終用戶
  • 醫院和多專科醫療中心、門診手術中心、專科疼痛診所、神經內科和神經外科診所、復健中心和長期護理機構、研究和學術醫療中心。
  • 按類型細分：脊髓刺激設備
  • 充電式脊髓刺激設備、不充電式脊髓刺激設備、傳統脊髓刺激設備、高頻脊髓刺激設備、脈衝串刺激型脊髓刺激設備、封閉回路型式脊髓刺激設備
  • 按類型細分：深部腦部刺激裝置
  • 單通道深部腦部刺激器、雙通道深部腦部刺激器、可充電式深部腦部刺激器、不可充電式深部腦部刺激器、恆流式深部腦部刺激器、恆壓式深部腦部刺激器
  • 按類型細分：薦骨神經調節裝置
  • 植入式薦骨神經調節裝置、可充電式骶薦骨神經調節裝置、不可充電式薦骨神經調節裝置、無線薦骨神經調節裝置、經皮薦骨神經調節裝置
  • 按類型細分：周邊神經刺激設備
  • 植入式周邊神經刺激設備、經皮周邊神經刺激設備、無線周邊神經刺激設備、可充電周邊神經刺激設備、不可充電周邊神經刺激設備、暫時性周邊神經刺激設備
  • 按類型細分：迷走神經刺激設備
  • 植入式迷走神經刺激設備、體外迷走神經刺激設備、充電式迷走神經刺激設備、不可充電式迷走神經刺激設備、封閉回路型迷走神經刺激設備、開放回路型迷走神經刺激設備

第10章 區域與國別分析

第11章 亞太市場

第12章：中國市場

第13章：印度市場

第14章：日本市場

第15章：澳洲市場

第16章：印尼市場

第17章：韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章 西歐市場

第21章英國市場

第22章：德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章：東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章：南美市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 植入式神經調控與脊髓刺激設備市場：競爭格局與市場佔有率，2024 年
  • 植入式神經調控與脊髓刺激設備市場：公司估價矩陣
  • 植入式神經調控與脊髓刺激設備市場：公司概況
    • Medtronic plc
    • Abbott Laboratories
    • Boston Scientific Corporation
    • LivaNova PLC
    • Nevro Corp.

第37章 其他大型企業和創新企業

  • NeuroPace Inc., Saluda Medical Pty Ltd., Mainstay Medical Holdings plc, Integer Holdings Corporation, Biotronik SE & Co. KG, Cirtec Medical Corporation, Neuspera Medical Inc., ONWARD Medical, Neuros Medical, Synchron, Synapse Biomedical Inc., CorTec GmbH, Aleva Neurotherapeutics SA, Gimer Medical Co. Ltd., SceneRay Corporation

第38章：全球市場競爭基準分析與儀錶板

第39章：預計進入市場的新創企業

第40章 重大併購

第41章 具有高市場潛力的國家、細分市場與策略

  • 2030年植入式神經調控與脊髓刺激設備市場：提供新機會的國家
  • 2030年植入式神經調控與脊髓刺激設備市場：充滿新機會的細分市場
  • 植入式神經調控與脊髓刺激設備市場，2030 年：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第42章附錄

簡介目錄
Product Code: ME5MINSC01_G26Q2

Implantable neuromodulation and spinal cord stimulation devices are implantable medical devices designed to deliver controlled electrical impulses to targeted nerves or the spinal cord to modulate nerve signaling activity. These devices use programmable stimulation technology and implantable pulse generators to provide precise and long-term neuromodulation within the body.

The primary device types of implantable neuromodulation and spinal cord stimulation devices include spinal cord stimulators, deep brain stimulators, sacral neuromodulation devices, peripheral nerve stimulators, and vagus nerve stimulators. Spinal cord stimulators refer to implantable medical devices that deliver electrical impulses to the spinal cord to modulate pain signals and manage chronic neurological conditions. These devices use technologies such as closed-loop adaptive systems, rechargeable implantable pulse generators, non-rechargeable implantable pulse generators, and wireless and remote programmable systems. The various applications involved are chronic pain management, Parkinson's and movement disorders, spinal cord injury and paralysis restoration, bladder and bowel dysfunction, and epilepsy and neurological disorders, and they are utilized by end users including hospitals and multispecialty centers, ambulatory surgical centers, specialty pain clinics, neurology and neurosurgery clinics, rehabilitation centers and long-term care facilities, and research and academic medical centers.

Tariffs are influencing the implantable neuromodulation and spinal cord stimulation devices market by increasing the cost of imported advanced medical components such as implantable pulse generators, microelectronic control systems, and biocompatible electrode materials used in device manufacturing. This is raising overall production costs and limiting affordability, particularly in import-dependent regions such as Asia-Pacific and Latin America where high-end neuromodulation devices are largely sourced from global manufacturers. Segments such as rechargeable implantable pulse generators and closed-loop spinal cord stimulation systems are most affected due to reliance on highly specialized semiconductor and precision engineering supply chains. However, tariffs are also encouraging regional manufacturing expansion, localized supply chain development, and increased investment in domestic neurotechnology production capabilities, ultimately strengthening long-term market resilience and innovation capacity.

The implantable neuromodulation and spinal cord stimulation devices market size has grown rapidly in recent years. It will grow from $9.31 billion in 2025 to $10.53 billion in 2026 at a compound annual growth rate (CAGR) of 13.1%. The growth in the historic period can be attributed to growth in chronic pain prevalence worldwide, increasing adoption of spinal cord stimulation for pain management, expansion of neurology treatment infrastructure, rising acceptance of implantable medical devices, early advancements in implantable pulse generator technology.

The implantable neuromodulation and spinal cord stimulation devices market size is expected to see rapid growth in the next few years. It will grow to $16.96 billion in 2030 at a compound annual growth rate (CAGR) of 12.6%. The growth in the forecast period can be attributed to integration of ai-driven adaptive neuromodulation systems, increasing demand for minimally invasive neurological therapies, growth in personalized and precision neurology treatments, rising adoption of wireless implantable medical devices, advancement in closed-loop neurostimulation technologies. Major trends in the forecast period include rising adoption of closed loop adaptive neuromodulation systems for real time pain management optimization, increasing demand for rechargeable implantable pulse generators to reduce surgical replacement procedures, growing use of spinal cord stimulation devices for chronic pain and neuropathic conditions, expansion of wireless and remotely programmable neuromodulation devices for personalized therapy delivery, rising integration of sacral neuromodulation devices for bladder and bowel dysfunction treatments.

The growing incidence of neurological disorders is expected to propel the growth of the implantable neuromodulation and spinal cord stimulation devices market going forward. Neurological disorders are diseases of the nervous system that impair the functioning of the brain, spinal cord, or peripheral nerves, leading to physical, cognitive, or behavioral abnormalities. Neurological disorders are increasing due to the rising prevalence of diabetes, as prolonged high blood sugar levels can damage nerves and blood vessels, increasing the risk of neurological conditions such as neuropathy, stroke, and cognitive impairment. Implantable neuromodulation and spinal cord stimulation devices help manage neurological disorders by delivering controlled electrical impulses to specific nerves or areas of the spinal cord and brain, helping reduce chronic pain, restore nerve signaling, and improve symptoms associated with conditions such as Parkinson's disease, epilepsy, and spinal cord injuries. For instance, in December 2025, according to the Australian Institute of Health and Welfare, an Australia-based government agency, in 2024, approximately 425,000 Australians were living with dementia (a type of neurological disorder), and this number is projected to increase 2.5 times to over 1.1 million by 2065, including around 662,000 women and 390,000 men. Therefore, the growing incidence of neurological disorders is driving the growth of the implantable neuromodulation and spinal cord stimulation devices market.

The increasing healthcare expenditure is expected to propel the growth of the implantable neuromodulation and spinal cord stimulation devices market going forward. Healthcare expenditure is the total spending by governments, organizations, and individuals on medical services, healthcare products, and activities aimed at maintaining or improving health. Healthcare expenditure is increasing due to advancements in medical technology, as the adoption of innovative diagnostic tools, robotic surgeries, and advanced treatment procedures improves patient care but also raises the overall cost of healthcare services. Increasing healthcare expenditure supports the growth of implantable neuromodulation and spinal cord stimulation devices by enabling greater investment in advanced pain management technologies, improving patient access to implantable therapies, and expanding healthcare infrastructure for specialized neurological treatments. For instance, in April 2025, according to the Office for National Statistics, a UK-based independent producer of official statistics, in 2024, the UK's healthcare spending reached around $370.71 billion (£317 billion), reflecting a 6.5% nominal increase compared with 2023. Therefore, the increasing healthcare expenditure is driving the growth of the implantable neuromodulation and spinal cord stimulation devices market.

Major companies operating in the implantable neuromodulation and spinal cord stimulation devices market are focusing on developing innovative solutions such as closed-loop, rechargeable spinal cord stimulators to provide personalized pain management, enhance therapy effectiveness, and improve patient comfort through adaptive real-time stimulation. A closed-loop rechargeable spinal cord stimulator is an implantable device that automatically adjusts electrical nerve stimulation in real time to maintain consistent pain relief and operates with a rechargeable battery for long-term use. For instance, in April 2024, Medtronic plc, an Ireland-based medical device company, launched Inceptiv, a closed-loop rechargeable spinal cord stimulator (SCS). The product received approval from the Food and Drug Administration (FDA) for the treatment of chronic pain in the trunk and/or limbs, including unilateral or bilateral pain. The device detects evoked compound action potentials (ECAPs) or similar biological signals along the spinal cord and uses them as a real-time biomarker of dorsal column activation.

Major companies operating in the implantable neuromodulation and spinal cord stimulation devices market are Medtronic plc; Abbott Laboratories; Boston Scientific Corporation; LivaNova PLC; Nevro Corp.; NeuroPace Inc.; Saluda Medical Pty Ltd.; Mainstay Medical Holdings plc; Integer Holdings Corporation; Biotronik SE & Co. KG; Cirtec Medical Corporation; Neuspera Medical Inc.; ONWARD Medical; Neuros Medical; Synchron; Synapse Biomedical Inc.; CorTec GmbH; Aleva Neurotherapeutics SA; Gimer Medical Co. Ltd.; SceneRay Corporation; Nexstim Plc

North America was the largest region in the implantable neuromodulation and spinal cord stimulation devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the implantable neuromodulation and spinal cord stimulation devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the implantable neuromodulation and spinal cord stimulation devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The implantable neuromodulation and spinal cord stimulation devices market consists of sales of dorsal root ganglion stimulation devices, gastric electrical stimulation devices, and hypoglossal nerve stimulation devices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The implantable neuromodulation and spinal cord stimulation devices market research report is one of a series of new reports from The Business Research Company that provides implantable neuromodulation and spinal cord stimulation devices market statistics, including implantable neuromodulation and spinal cord stimulation devices industry global market size, regional shares, competitors with a implantable neuromodulation and spinal cord stimulation devices market share, detailed implantable neuromodulation and spinal cord stimulation devices market segments, market trends and opportunities, and any further data you may need to thrive in the implantable neuromodulation and spinal cord stimulation devices industry. This implantable neuromodulation and spinal cord stimulation devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Implantable Neuromodulation And Spinal Cord Stimulation Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses implantable neuromodulation and spinal cord stimulation devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for implantable neuromodulation and spinal cord stimulation devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The implantable neuromodulation and spinal cord stimulation devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Device Type: Spinal Cord Stimulators; Deep Brain Stimulators; Sacral Neuromodulation Devices; Peripheral Nerve Stimulators; Vagus Nerve Stimulators
  • 2) By Technology: Closed Loop Adaptive Systems; Rechargeable Implantable Pulse Generators; Non Rechargeable Implantable Pulse Generators; Wireless And Remote Programmable Systems
  • 3) By Application: Chronic Pain Management; Parkinson's And Movement Disorders; Spinal Cord Injury And Paralysis Restoration; Bladder And Bowel Dysfunction; Epilepsy And Neurological Disorders
  • 4) By End User: Hospitals And Multispecialty Centers; Ambulatory Surgical Centers; Specialty Pain Clinics; Neurology And Neurosurgery Clinics; Rehabilitation Centers And Long Term Care Facilities; Research And Academic Medical Centers
  • Subsegments:
  • 1) By Spinal Cord Stimulators: Rechargeable Spinal Cord Stimulators; Non Rechargeable Spinal Cord Stimulators; Conventional Spinal Cord Stimulators; High Frequency Spinal Cord Stimulators; Burst Stimulation Spinal Cord Stimulators; Closed Loop Spinal Cord Stimulators
  • 2) By Deep Brain Stimulators: Single Channel Deep Brain Stimulators; Dual Channel Deep Brain Stimulators; Rechargeable Deep Brain Stimulators; Non Rechargeable Deep Brain Stimulators; Constant Current Deep Brain Stimulators; Constant Voltage Deep Brain Stimulators
  • 3) By Sacral Neuromodulation Devices: Implantable Sacral Neuromodulation Devices; Rechargeable Sacral Neuromodulation Devices; Non Rechargeable Sacral Neuromodulation Devices; Wireless Sacral Neuromodulation Devices; Percutaneous Sacral Neuromodulation Devices
  • 4) By Peripheral Nerve Stimulators: Implantable Peripheral Nerve Stimulators; Percutaneous Peripheral Nerve Stimulators; Wireless Peripheral Nerve Stimulators; Rechargeable Peripheral Nerve Stimulators; Non Rechargeable Peripheral Nerve Stimulators; Temporary Peripheral Nerve Stimulators
  • 5) By Vagus Nerve Stimulators: Implantable Vagus Nerve Stimulators; External Vagus Nerve Stimulators; Rechargeable Vagus Nerve Stimulators; Non Rechargeable Vagus Nerve Stimulators; Closed Loop Vagus Nerve Stimulators; Open Loop Vagus Nerve Stimulators
  • Companies Mentioned: Medtronic plc; Abbott Laboratories; Boston Scientific Corporation; LivaNova PLC; Nevro Corp.; NeuroPace Inc.; Saluda Medical Pty Ltd.; Mainstay Medical Holdings plc; Integer Holdings Corporation; Biotronik SE & Co. KG; Cirtec Medical Corporation; Neuspera Medical Inc.; ONWARD Medical; Neuros Medical; Synchron; Synapse Biomedical Inc.; CorTec GmbH; Aleva Neurotherapeutics SA; Gimer Medical Co. Ltd.; SceneRay Corporation; Nexstim Plc
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Implantable Neuromodulation And Spinal Cord Stimulation Devices Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Implantable Neuromodulation And Spinal Cord Stimulation Devices Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Implantable Neuromodulation And Spinal Cord Stimulation Devices Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Implantable Neuromodulation And Spinal Cord Stimulation Devices Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Artificial Intelligence & Autonomous Intelligence
    • 4.1.4 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems
    • 4.1.5 Immersive Technologies (AR/VR/XR) & Digital Experiences
  • 4.2. Major Trends
    • 4.2.1 Rising Adoption Of Closed Loop Adaptive Neuromodulation Systems For Real Time Pain Management Optimization
    • 4.2.2 Increasing Demand For Rechargeable Implantable Pulse Generators To Reduce Surgical Replacement Procedures
    • 4.2.3 Growing Use Of Spinal Cord Stimulation Devices For Chronic Pain And Neuropathic Conditions
    • 4.2.4 Expansion Of Wireless And Remotely Programmable Neuromodulation Devices For Personalized Therapy Delivery
    • 4.2.5 Rising Integration Of Sacral Neuromodulation Devices For Bladder And Bowel Dysfunction Treatments

5. Implantable Neuromodulation And Spinal Cord Stimulation Devices Market Analysis Of End Use Industries

  • 5.1 Hospitals And Multispecialty Centers
  • 5.2 Ambulatory Surgical Centers
  • 5.3 Specialty Pain Clinics
  • 5.4 Neurology And Neurosurgery Clinics
  • 5.5 Others

6. Implantable Neuromodulation And Spinal Cord Stimulation Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Implantable Neuromodulation And Spinal Cord Stimulation Devices Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Implantable Neuromodulation And Spinal Cord Stimulation Devices PESTEL Analysis (Political, Economical, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Implantable Neuromodulation And Spinal Cord Stimulation Devices Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Implantable Neuromodulation And Spinal Cord Stimulation Devices Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Implantable Neuromodulation And Spinal Cord Stimulation Devices Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Implantable Neuromodulation And Spinal Cord Stimulation Devices Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Implantable Neuromodulation And Spinal Cord Stimulation Devices Market Segmentation

  • 9.1. Global Implantable Neuromodulation And Spinal Cord Stimulation Devices Market, Segmentation By Device Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Spinal Cord Stimulators, Deep Brain Stimulators, Sacral Neuromodulation Devices, Peripheral Nerve Stimulators, Vagus Nerve Stimulators
  • 9.2. Global Implantable Neuromodulation And Spinal Cord Stimulation Devices Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Closed Loop Adaptive Systems, Rechargeable Implantable Pulse Generators, Non Rechargeable Implantable Pulse Generators, Wireless And Remote Programmable Systems
  • 9.3. Global Implantable Neuromodulation And Spinal Cord Stimulation Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Chronic Pain Management, Parkinson's And Movement Disorders, Spinal Cord Injury And Paralysis Restoration, Bladder And Bowel Dysfunction, Epilepsy And Neurological Disorders
  • 9.4. Global Implantable Neuromodulation And Spinal Cord Stimulation Devices Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals And Multispecialty Centers, Ambulatory Surgical Centers, Specialty Pain Clinics, Neurology And Neurosurgery Clinics, Rehabilitation Centers And Long Term Care Facilities, Research And Academic Medical Centers
  • 9.5. Global Implantable Neuromodulation And Spinal Cord Stimulation Devices Market, Sub-Segmentation Of Spinal Cord Stimulators, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Rechargeable Spinal Cord Stimulators, Non Rechargeable Spinal Cord Stimulators, Conventional Spinal Cord Stimulators, High Frequency Spinal Cord Stimulators, Burst Stimulation Spinal Cord Stimulators, Closed Loop Spinal Cord Stimulators
  • 9.6. Global Implantable Neuromodulation And Spinal Cord Stimulation Devices Market, Sub-Segmentation Of Deep Brain Stimulators, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Single Channel Deep Brain Stimulators, Dual Channel Deep Brain Stimulators, Rechargeable Deep Brain Stimulators, Non Rechargeable Deep Brain Stimulators, Constant Current Deep Brain Stimulators, Constant Voltage Deep Brain Stimulators
  • 9.7. Global Implantable Neuromodulation And Spinal Cord Stimulation Devices Market, Sub-Segmentation Of Sacral Neuromodulation Devices, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Implantable Sacral Neuromodulation Devices, Rechargeable Sacral Neuromodulation Devices, Non Rechargeable Sacral Neuromodulation Devices, Wireless Sacral Neuromodulation Devices, Percutaneous Sacral Neuromodulation Devices
  • 9.8. Global Implantable Neuromodulation And Spinal Cord Stimulation Devices Market, Sub-Segmentation Of Peripheral Nerve Stimulators, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Implantable Peripheral Nerve Stimulators, Percutaneous Peripheral Nerve Stimulators, Wireless Peripheral Nerve Stimulators, Rechargeable Peripheral Nerve Stimulators, Non Rechargeable Peripheral Nerve Stimulators, Temporary Peripheral Nerve Stimulators
  • 9.9. Global Implantable Neuromodulation And Spinal Cord Stimulation Devices Market, Sub-Segmentation Of Vagus Nerve Stimulators, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Implantable Vagus Nerve Stimulators, External Vagus Nerve Stimulators, Rechargeable Vagus Nerve Stimulators, Non Rechargeable Vagus Nerve Stimulators, Closed Loop Vagus Nerve Stimulators, Open Loop Vagus Nerve Stimulators

10. Implantable Neuromodulation And Spinal Cord Stimulation Devices Market Regional And Country Analysis

  • 10.1. Global Implantable Neuromodulation And Spinal Cord Stimulation Devices Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Implantable Neuromodulation And Spinal Cord Stimulation Devices Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Implantable Neuromodulation And Spinal Cord Stimulation Devices Market

  • 11.1. Asia-Pacific Implantable Neuromodulation And Spinal Cord Stimulation Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Implantable Neuromodulation And Spinal Cord Stimulation Devices Market, Segmentation By Device Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Implantable Neuromodulation And Spinal Cord Stimulation Devices Market

  • 12.1. China Implantable Neuromodulation And Spinal Cord Stimulation Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Implantable Neuromodulation And Spinal Cord Stimulation Devices Market, Segmentation By Device Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Implantable Neuromodulation And Spinal Cord Stimulation Devices Market

  • 13.1. India Implantable Neuromodulation And Spinal Cord Stimulation Devices Market, Segmentation By Device Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Implantable Neuromodulation And Spinal Cord Stimulation Devices Market

  • 14.1. Japan Implantable Neuromodulation And Spinal Cord Stimulation Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Implantable Neuromodulation And Spinal Cord Stimulation Devices Market, Segmentation By Device Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Implantable Neuromodulation And Spinal Cord Stimulation Devices Market

  • 15.1. Australia Implantable Neuromodulation And Spinal Cord Stimulation Devices Market, Segmentation By Device Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Implantable Neuromodulation And Spinal Cord Stimulation Devices Market

  • 16.1. Indonesia Implantable Neuromodulation And Spinal Cord Stimulation Devices Market, Segmentation By Device Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Implantable Neuromodulation And Spinal Cord Stimulation Devices Market

  • 17.1. South Korea Implantable Neuromodulation And Spinal Cord Stimulation Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Implantable Neuromodulation And Spinal Cord Stimulation Devices Market, Segmentation By Device Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Implantable Neuromodulation And Spinal Cord Stimulation Devices Market

  • 18.1. Taiwan Implantable Neuromodulation And Spinal Cord Stimulation Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Implantable Neuromodulation And Spinal Cord Stimulation Devices Market, Segmentation By Device Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Implantable Neuromodulation And Spinal Cord Stimulation Devices Market

  • 19.1. South East Asia Implantable Neuromodulation And Spinal Cord Stimulation Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Implantable Neuromodulation And Spinal Cord Stimulation Devices Market, Segmentation By Device Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Implantable Neuromodulation And Spinal Cord Stimulation Devices Market

  • 20.1. Western Europe Implantable Neuromodulation And Spinal Cord Stimulation Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Implantable Neuromodulation And Spinal Cord Stimulation Devices Market, Segmentation By Device Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Implantable Neuromodulation And Spinal Cord Stimulation Devices Market

  • 21.1. UK Implantable Neuromodulation And Spinal Cord Stimulation Devices Market, Segmentation By Device Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Implantable Neuromodulation And Spinal Cord Stimulation Devices Market

  • 22.1. Germany Implantable Neuromodulation And Spinal Cord Stimulation Devices Market, Segmentation By Device Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Implantable Neuromodulation And Spinal Cord Stimulation Devices Market

  • 23.1. France Implantable Neuromodulation And Spinal Cord Stimulation Devices Market, Segmentation By Device Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Implantable Neuromodulation And Spinal Cord Stimulation Devices Market

  • 24.1. Italy Implantable Neuromodulation And Spinal Cord Stimulation Devices Market, Segmentation By Device Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Implantable Neuromodulation And Spinal Cord Stimulation Devices Market

  • 25.1. Spain Implantable Neuromodulation And Spinal Cord Stimulation Devices Market, Segmentation By Device Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Implantable Neuromodulation And Spinal Cord Stimulation Devices Market

  • 26.1. Eastern Europe Implantable Neuromodulation And Spinal Cord Stimulation Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Implantable Neuromodulation And Spinal Cord Stimulation Devices Market, Segmentation By Device Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Implantable Neuromodulation And Spinal Cord Stimulation Devices Market

  • 27.1. Russia Implantable Neuromodulation And Spinal Cord Stimulation Devices Market, Segmentation By Device Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Implantable Neuromodulation And Spinal Cord Stimulation Devices Market

  • 28.1. North America Implantable Neuromodulation And Spinal Cord Stimulation Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Implantable Neuromodulation And Spinal Cord Stimulation Devices Market, Segmentation By Device Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Implantable Neuromodulation And Spinal Cord Stimulation Devices Market

  • 29.1. USA Implantable Neuromodulation And Spinal Cord Stimulation Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Implantable Neuromodulation And Spinal Cord Stimulation Devices Market, Segmentation By Device Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Implantable Neuromodulation And Spinal Cord Stimulation Devices Market

  • 30.1. Canada Implantable Neuromodulation And Spinal Cord Stimulation Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Implantable Neuromodulation And Spinal Cord Stimulation Devices Market, Segmentation By Device Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Implantable Neuromodulation And Spinal Cord Stimulation Devices Market

  • 31.1. South America Implantable Neuromodulation And Spinal Cord Stimulation Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Implantable Neuromodulation And Spinal Cord Stimulation Devices Market, Segmentation By Device Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Implantable Neuromodulation And Spinal Cord Stimulation Devices Market

  • 32.1. Brazil Implantable Neuromodulation And Spinal Cord Stimulation Devices Market, Segmentation By Device Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Implantable Neuromodulation And Spinal Cord Stimulation Devices Market

  • 33.1. Middle East Implantable Neuromodulation And Spinal Cord Stimulation Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Implantable Neuromodulation And Spinal Cord Stimulation Devices Market, Segmentation By Device Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Implantable Neuromodulation And Spinal Cord Stimulation Devices Market

  • 34.1. Africa Implantable Neuromodulation And Spinal Cord Stimulation Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Implantable Neuromodulation And Spinal Cord Stimulation Devices Market, Segmentation By Device Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Implantable Neuromodulation And Spinal Cord Stimulation Devices Market Regulatory and Investment Landscape

36. Implantable Neuromodulation And Spinal Cord Stimulation Devices Market Competitive Landscape And Company Profiles

  • 36.1. Implantable Neuromodulation And Spinal Cord Stimulation Devices Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Implantable Neuromodulation And Spinal Cord Stimulation Devices Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Implantable Neuromodulation And Spinal Cord Stimulation Devices Market Company Profiles
    • 36.3.1. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. LivaNova PLC Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Nevro Corp. Overview, Products and Services, Strategy and Financial Analysis

37. Implantable Neuromodulation And Spinal Cord Stimulation Devices Market Other Major And Innovative Companies

  • NeuroPace Inc., Saluda Medical Pty Ltd., Mainstay Medical Holdings plc, Integer Holdings Corporation, Biotronik SE & Co. KG, Cirtec Medical Corporation, Neuspera Medical Inc., ONWARD Medical, Neuros Medical, Synchron, Synapse Biomedical Inc., CorTec GmbH, Aleva Neurotherapeutics SA, Gimer Medical Co. Ltd., SceneRay Corporation

38. Global Implantable Neuromodulation And Spinal Cord Stimulation Devices Market Competitive Benchmarking And Dashboard

39. Upcoming Startups in the Market

40. Key Mergers And Acquisitions In The Implantable Neuromodulation And Spinal Cord Stimulation Devices Market

41. Implantable Neuromodulation And Spinal Cord Stimulation Devices Market High Potential Countries, Segments and Strategies

  • 41.1 Implantable Neuromodulation And Spinal Cord Stimulation Devices Market In 2030 - Countries Offering Most New Opportunities
  • 41.2 Implantable Neuromodulation And Spinal Cord Stimulation Devices Market In 2030 - Segments Offering Most New Opportunities
  • 41.3 Implantable Neuromodulation And Spinal Cord Stimulation Devices Market In 2030 - Growth Strategies
    • 41.3.1 Market Trend Based Strategies
    • 41.3.2 Competitor Strategies

42. Appendix

  • 42.1. Abbreviations
  • 42.2. Currencies
  • 42.3. Historic And Forecast Inflation Rates
  • 42.4. Research Inquiries
  • 42.5. The Business Research Company
  • 42.6. Copyright And Disclaimer